Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Commentary on: Feig DS, Donovan LE, Corcoy R, et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial. Lancet 2017;390(10110):2347-59.
Risk of adverse obstetric and neonatal outcomes in pregnant women with type 1 diabetes can be reduced with more intense glycaemic control,1 but achieving targets is challenging. Indeed, with specialist input, only 40% of women achieve optimal glycaemic control during pregnancy.2
Real-time continuous glucose monitoring (rt-CGM) provides rich information on direction and rate of change of interstitial glucose. This assists patients to modify behaviours, diet, exercise and insulin dosing with immediate feedback and corrective actions possible to minimise glucose excursions. To date, randomised trials of CGM in pregnancy have been limited.
CONCEPTT is a multicentre open-label randomised controlled trial (RCT) of reproductive age women with type 1 diabetes on intensive insulin therapy.3 Women in the first trimester …
Contributors This commentary was drafted and edited by SKA and SZ. Both authors approved the final manuscript.
Competing interests None declared.
Provenance and peer review Commissioned; internally peer reviewed.